922
T. Angles d’Ortoli, G. Widmalm / Tetrahedron 72 (2016) 912e927
JH5,H6b 1.61, Jgem 12.42, 1H, H-6b), 4.30 (d, JH1,H2 7.80, 1H, H-1), 4.29
(dd, JH,CH2a 7.84, JH,CH2b 5.19, 1H, ArCHCH2OCO), 4.10 (dd, JH1,H2 7.80,
JH2,H3 10.12, 1H, H-2), 4.08 (dd, JH5,H6a 1.83, Jgem 12.42, 1H, H-6a),
3.60 (s, 3H, OMe), 3.51 (ddd, JH4,H5 1.01, JH5,H6a 1.83, JH5,H6b 1.61, 1H,
white solids 20a, 20b and 20c in 18, 25 and 25% yield, respectively.
20a: 1H NMR (CDCl3, 25 ꢀC, 400 MHz):
7.47e7.26 (m, 10H, HeAr),
d
5.21 (d, JH1,H2 2.80, 1H, G), 5.19 (s, 1H, CHPh), 5.19 (dd, JH1,H2 8.04,
JH2,H3 10.02, 1H, H-2 Gal), 4.92 (d, JH1,H2 6.08, 1H, H-1 G0), 4.61 (d,
Jgem 12.04, 1H, PhCH2 G), 4.48 (d, Jgem 12.04, 1H, PhCH2 G), 4.43 (dd,
JH3,H4 3.32, JH4,H5 0.79, 1H, H-4 Gal), 4.31 (d, JH1,H2 8.04, 1H, H-1 Gal),
4.12 (dd, JH3,H4 5.41, JH4,H5 10.71, 1H, H-4 G), 4.00 (dd, JH5,H6b 1.39,
Jgem 12.16, 1H, H-6b Gal), 3.99 (dd, 1H, H-4 G0), 3.87 (ddd, JH4,H5
10.61, JH5,H6a 2.54, JH5,H6b 4.02, 1H, H-5 G), 3.81 (dd, 1H, H-2 G), 3.79
(dd, 1H, H-3 G), 3.78 (ddd, 1H, H-5 G0), 3.77 (dd, 1H, H-3 Gal), 3.76
(dd, 1H, H-6b G0), 3.75 (dd, 1H, H-3 G0), 3.66 (dd, JH5,H6b 4.02, 1H, H-
6b G), 3.63 (dd, 1H, H-6a G0), 3.62 (dd, JH5,H6a 2.54, 1H, H-6a G), 3.58
(dd, 1H, H-2 G0), 3.46 (s, 3H, OMe Gal), 3.29 (dd, JH5,H6a 1.75, Jgem
12.16, 1H, H-6a Gal), 3.12 (ddd, JH4,H5 0.79, JH5,H6a 1.75, JH5,H6b 1.39,
1H, H-5 Gal), 2.05 (s, 3H, CH3), 0.90, 0.89, 0.88, 0.87, 0.80, 0.75 (6 s,
54H, C(CH3)3), 0.11, 0.10e0.05, ꢁ0.012, ꢁ0.13, ꢁ0.14 (12 s, 36H,
H-5), 2.44 (nr, 1H, OH-2). 13C NMR (CDCl3, 25 ꢀC, 100 MHz):
d 154.8
(ArCHCH2OC]O), 143.5, 143.2, 2ꢂ141.4, 137.6, (5 C-ipso), 129.1,
2ꢂ128.3, 2ꢂ128.0, 127.3, 127.3, 2ꢂ126.4, 2ꢂ125.4, 2ꢂ120.2
(13 CeAr), 104.0 (C-1), 101.0 (CHPh), 77.4 (C-3), 73.3 (C-4), 70.3
(ArCHCH2OCO), 69.1 (C-6), 68.7 (C-2), 66.5 (C5), 57.4 (OMe), 46.8
(ArCHCH2OCO). ESI-HRMS: [MþNa]þ m/z calcd for C29H28O8Na
527.1682, found 527.1679.
4.1.14. Methyl 2,3,4-tri-O-acetyl-
a
-L-rhamnopyranosyl-(1/2)-4,6-
O-benzylidene- -galactopyranoside (19). A solution of thioglyco-
b-D
side 17 (100 mg, 0.3 mmol, 1.5 equiv) and acceptor 18 (100 mg,
0.2 mmol) in dry CH2CL2 was stirred for 20 min in the presence of
molecular sieves (4 A, 0.4 g) under N2 atmosphere. NIS (2 equiv)
SiCH3). 13C NMR (CDCl3, 25 ꢀC, 100 MHz):
d 169.1 (C]O Gal), 138.6,
ꢁ
and AgOTf (0.5 equiv) were added at 0 ꢀC. The reaction was mon-
itored by TLC and left to stir at room temperature for one hour. Once
the acceptor was consumed, TEA (25 equiv) was added to quench
the reaction and to cleave the FMOC protecting group. After 30 min
(Rf¼0.56 Pentane/EtOAc 1:2), the mixture was filtered through
Celite. It was then diluted with CH2Cl2 and washed successively
with solutions of satd Na2S2O3, brine and dried over Na2SO4. The
solvent was removed in vacuo and the residue thus obtained was
purified by flash chromatography to yield 90 mg of 19 as a white
138.1 (2 C-ipso), 2ꢂ128.7, 2ꢂ128.3, 4ꢂ128.1, 2ꢂ126.7 (10 CeAr),
102.0 (C-1 Gal), 101.9 (C-1 G0), 101.6 (C-1 G), 100.8 (CHPh Gal), 81.8
(C-5 G0), 79.9 (C-2 G), 79.7 (C-3 G0), 78.8 (C-3 G), 77.7 (C-2 G0), 77.1
(C-3 Gal), 75.7 (C-4 Gal), 73.5 (PhCH2 G), 72.9 (C-5 G), 72.5 (C-4 G),
70.4 (C-2 Gal), 70.2 (C-6 G), 70.2 (C-4 G0), 68.7 (C-6 Gal), 66.9 (C-5
Gal), 64.1 (C-6 G0), 55.8 (OMe Gal), 26.15, 26.1e26.0 (6 C(CH3)3), 21.1
(CH3), 18.4e18.1 (6 C(CH3)3), ꢁ2.8 to ꢁ5.2 (12 SiCH3). 20b and 20c:
1H NMR (CDCl3, 25 ꢀC, 400 MHz):
d 7.51e7.29 (m, 10H, HeAr), 5.56
(s, 1H, CHPh Gal 20c), 5.33 (dd, JH1,H2 8.07, JH2,H3 9.93, 1H, H-2 Gal
20c), 5.30 (s, 1H, CHPh Gal 20b), 5.25 (dd, JH1,H2 8.00, JH2,H3 10.20,
1H, H-2 Gal 20b), 5.04 (d, JH1,H2 6.38, 1H, H-1 G0 20b), 5.02 (d, JH1,H2
3.49, 1H, H-1 G 20c), 4.89 (d, JH1,H2 5.30, 1H, H-1 G0 20c), 4.83 (d,
JH1,H2 5.03, 1H, H-1 G 20b), 4.58e4.52 (2 d, Jgem 12.19, 2H, PhCH2 G,
20b), 4.54e4.49 (2 d, Jgem 11.68, 2H, PhCH2 G, 20c), 4.40 (dd, JH3,H4
3.35, JH4,H5 0.51, 1H, H-4 Gal, 20c), 4.37 (dd, JH3,H4 3.53, JH4,H5 0.51,
1H, H-4 Gal, 20b), 4.325 (d, JH1,H2 8.00, 1H, H-1 Gal, 20b), 4.32 (dd,
JH5,H6b 1.51, Jgem 12.38, 1H, H-6b Gal, 20c), 4.30 (d, JH1,H2 8.07, 1H, H-
1 Gal, 20c), 4.08 (dd, JH5,H6b 1.52, Jgem 12.30, 1H, H-6b Gal, 20b), 4.03
(dd, JH5,H6a 1.76, Jgem 12.38, 1H, H-6a Gal, 20c), 3.96 (m, 1H, H-4 G0,
20b), 3.91 (dd, JH2,H3 8.81, JH3,H4 8.32,1H, H-3 G, 20c), 3.84 (dd, JH2,H3
9.93, JH3,H4 3.35, 1H, H-3 Gal, 20c), 3.81 (ddd, 1H, H-5 G, 20c), 3.80
(dd, JH2,H3 10.20, JH3,H4 3.53, 1H, H-3 Gal, 20b), 3.77 (dd, 1H, H-3 G0,
20b), 3.75 (ddd, 1H, H-5 G, 20b), 3.74 (dd, 1H, H-4 G0, 20c), 3.74 (dd,
1H, H-3 G0, 20c), 3.73 (m, 2H, H-6b G0 20c, H-6b G 20b), 3.71 (ddd,
1H, H-5 G0, 20b), 3.71 (dd, 1H, H-4 G, 20b), 3.70 (m, 2H, H-6a, H-6b
G0, 20b), 3.69 (ddd, 1H, H-5 G0, 20c), 3.67 (dd, 1H, H-6b G, 20c), 3.62
(m, 2H, H-2 G 20c, H-2 G 20b), 3.62 (dd, 1H, H-6a G0, 20c), 3.61 (dd,
1H, H-6a G, 20b), 3.59 (dd, 1H, H-2 G0, 20c), 3.58 (dd, 1H, H-2 G0,
20b), 3.55 (dd, 1H, H-4 G, 20c), 3.54 (dd, 1H, H-3 G, 20b), 3.53 (dd,
1H, H-6a G, 20c), 3.48 (s, 3H, OMe Gal, 20b), 3.48 (s, 3H, OMe Gal,
20c), 3.46 (dd, JH5,H6a 1.83, Jgem 12.30, 1H, H-6a Gal, 20b), 3.36 (ddd,
JH4,H5 0.51, JH5,H6a 1.76, JH5,H6b 1.51,1H, H-5 Gal, 20c), 3.11 (ddd, JH4,H5
0.51, JH5,H6a 1.83, JH5,H6b 1.52, 1H, H-5 Gal, 20b), 2.99 (nr, 1H, OH-3,
20b), 2.22 (nr, 1H, OH-4 20c), 2.06 (s, 3H, CH3, 20b), 2.02 (s, 3H, CH3,
20c), 0.91e0.83 (10 s, 90H, C(CH3)3), 0.14, 0.12e0.05, ꢁ0.05 (20s,
powder (82% yield). 1H NMR (CDCl3, 25 ꢀC, 400 MHz):
d 7.51e7.35
(m, 5H, HeAr Gal), 5.54 (s, 1H, CHPh Gal), 5.36 (dd, JH1,H2 1.73, JH2,H3
3.44, 1H, H-2 R), 5.28 (dd, JH2,H3 3.44, JH3,H4 10.09, 1H, H-3 R), 5.22
(d, JH1,H2 1.73, 1H, H-1 R), 5.01 (dd, JH3,H4 10.09, JH4,H5 10.02, 1H, H-4
R), 4.35 (dd, JH5,H6b 1.39, Jgem 12.45, 1H, H-6b Gal), 4.28 (d, JH1,H2
7.49, 1H, H-1 Gal), 4.23 (dq, JH4,H5 10.02, JH5,H6 6.29, 1H, H-5 R), 4.17
(dd, JH3,H4 3.61, JH4,H5 0.93, 1H, H-4 Gal), 4.08 (dd, JH5,H6a 1.81, Jgem
12.45, 1H, H-6a Gal), 3.82 (ddd, JH2,H3 9.20, JH3,H4 3.61, JH3,OH-3 10.03,
1H, H-3 Gal), 3.77 (dd, JH1,H2 7.49, JH2,H3 9.20, 1H, H-2 Gal), 3.56 (s,
3H, OMe Gal), 3.48 (ddd, JH4,H5 0.93, JH5,H6a 1.81, JH5,H6b 1.39, 1H, H-5
Gal), 2.50 (nr, 1H, OH-3 Gal). 2.12, 2.06, 1.98 (3 s, 9H, CH3 R), 1.20 (d,
JH5,H6 6.29, 3H, H-6 R). 13C NMR (CDCl3, 25 ꢀC, 100 MHz):
d 170.4,
2ꢂ170.2 (3C]O R), 137.4 (C-ipso Gal), 129.4, 2ꢂ128.4, 2ꢂ126.5
(5 CeAr Gal), 102.4 (C-1 Gal), 101.6 (CHPh Gal), 98.1 (C-1 R), 76.1 (C-
2 Gal), 75.8 (C-4 Gal), 73.8 (C-3 Gal), 71.2 (C-4 R), 69.9 (C-2 R), 69.5
(C-3 R), 69.2 (C-6 Gal), 66.6 (C-5 R), 66.6 (C-5 Gal), 56.9 (OMe Gal),
21.1, 21.0, 20.9 (CH3 R), 17.2 (C-6 R), ESI-HRMS: [MþNa]þ m/z calcd
for C26H34O13Na 577.1897, found 577.1901.
4.1.15. Methyl 2,3,4,6-tetra-O-tert-butyldimethylsilyl-
anosyl-(1/2)-3,4-di-O-tert-butyldimethylsilyl-6-O-benzyl-
copyranosyl-(1/3)-4,6-O-benzylidene-2-O-acetyl- -galactopyr-
anoside (20a). Methyl 2,3,4,6-tetra-O-tert-butyldimethylsilyl-
glucopyranosyl-(1/2)-4-O-tert-butyldimethylsilyl-6-O-benzyl-
glucopyranosyl-(1/3)-4,6-O-benzylidene-2-O-acetyl-
actopyranoside (20b). Methyl 2,3,4,6-tetra-O-tert-butyldimethylsilyl-
b-
D-glucopyr-
b-D
-glu-
b-D
b
-
D
D
-
-
b
-
b-D-gal-
b
-
-
D
-glucopyranosyl-(1/2)-3-O-tert-butyldimethylsilyl-6-O-benzyl-
-glucopyranosyl-(1/3)-4,6-O-benzylidene-2-O-acetyl- -gal-
60H, SiCH3). 13C NMR (CDCl3, 25 ꢀC, 100 MHz):
d 169.9 (C]O Gal,
b
D
b
-
D
20c), 169.5 (C]O Gal, 20b), 138.5, 138.2, 138.0, 137.9 (4 C-ipso),
129.0, 128.9, 2ꢂ128.7, 2ꢂ128.6, 8ꢂ128.2, 128.1, 2ꢂ128.0, 127.9,
2ꢂ126.6, 2ꢂ126.5 (20 CeAr), 103.2 (C-1 G0, 20c), 102.05 (C-1 G0,
20b), 102.0 (C-1 G, 20b), 102.0 (C-1 Gal, 20c), 101.9 (C-1 Gal, 20b),
101.8 (C-1 G, 20c), 101.1 (CHPh Gal, 20b), 100.9 (CHPh Gal, 20c), 82.2
(C-4 G0, 20c), 81.5 (C-5 G0, 20c), 80.3 (C-2 G, 20b), 79.8 (C-3 Gal,
20c), 79.6 (C-4 G0, 20b), 79.3 (C-3 G0, 20c), 79.0 (C-2 G, 20c), 78.9 (C-
2 G0, 20c), 77.9 (C-3 Gal, 20b), 77.8 (C-2 G0, 20b), 77.4 (C-3 G, 20b),
75.6 (C-4 Gal, 20b), 75.3 (C-4 Gal, 20c), 74.5 (C-3 G, 20c), 74.4 (C-5
G0, 20b), 73.7 (PhCH2 G, 20c), 73.6 (PhCH2 G, 20b), 72.6 (2 C-4 G,
20b, 20c), 71.6 (C-5 G, 20b), 70.4 (C-5 G, 20c), 70.4 (C-2 Gal, 20c),
70.3 (C-6 G, 20b), 69.9 (C-3 G0, 20b), 69.6 (C-2 Gal, 20b), 69.5 (C-6 G,
20c), 69.0 (C-6 Gal, 20c), 68.8 (C-6 Gal, 20b), 67.0 (C-5 Gal, 20c),
actopyranoside (20c). A 1 M solution of the promoter system
Tf2O-DMDS (1.1 equiv) in dry CH2Cl2 was added to the mixture
containing the armed-donor 14 (40 mg, 0.035 mmol), the acceptor
ꢁ
16 (1.2 equiv), 2,6-DTBMP (2 equiv) and activated 4 A molecular
sieves (100 mg) in dry CH2Cl2 (0.5 mL) at ꢁ78 ꢀC under N2 atmo-
sphere. The reaction mixture was stirred for 15 min and was
allowed to reach ꢁ40 ꢀC (20a Rf¼0.65, 20b, 20c Rf¼0.45 Pentane/
EtOAc 4:1). It was then quenched with NEt3 (3 equiv), diluted with
CH2Cl2, filtered through Celite and washed with a 2 M HCl solution,
aqueous NaHCO3 and brine. The organic phase was dried over
Na2SO4 and concentrated under vacuum. After evaporation, the
resulting material was purified by chromatography to afford as